Nigel Brooksby

Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.

Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom.

Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom.

Pertinax Pharma Ltd. manufactures pharmaceutical products. developing medical, healthcare and veterinary applications of a novel, proprietary long acting formulation of the already widely used antimicrobial drug chlorhexidine. Pertinax Pharma was founded by Michele Barbour in 2015 and is headquartered in Bristol, the United Kingdom.

Clinical Insights Ltd. engages in the provision of advisory services to the pharmaceutical industry. The company is headquartered in Milan, Italy.

Porton Biopharma Ltd. is a biopharmaceutical company based in Salisbury, UK. The British company is focused on the development and manufacture of biopharmaceutical products for the treatment of infectious diseases and cancer. Porton Biopharma is committed to delivering high-quality products that meet the needs of patients and healthcare providers. The CEO of the private company is Roger Hinton, who leads a team of experienced professionals dedicated to advancing the company's mission.

Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom.